Challenges of drug resistance in the developing world

BMJ (Online)

Volumn 344, Issue 7852, 2012, Pages

  Laxminarayan, Ramanan ^a,b   Heymann, David L ^c  

^a Center for Disease Dynamics Economics and Policy   (United States)

^b Center for Disease Dynamics Economics and Policy   (India)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLOROQUINE; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; COMMON COLD; COUGHING; DEVELOPING COUNTRY; DIARRHEA; DRUG INDUSTRY; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; DRUG USE; ESCHERICHIA COLI; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; HUMANS; WORLD HEALTH;

EID: 84859712185     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e1567     Document Type: Review

References (28)

1. Laxminarayan R. Economic issues related to antimicrobial resistance. In: Roberts JA, ed. The economics of infectious disease. Oxford University Press 2006: 49-64.
2. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005;5:481-93. (Pubitemid 41022024)
3. WHO. Community-based surveillance of antimicrobial use and resistance in resource-constrained settings: report on five pilot projects. WHO, 2009.
4. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
5. IMS Health. MIDAS market segmentation data. IMS, 2011.
6. Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, et al. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg 2008;79:320-30.
7. Dong H, Bogg L, Rehnberg C, Diwan V. Health financing policies: Providers' opinions and prescribing behavior in rural China. Int J Techn Assessm in Hlth Care 1999;15: 686-98. (Pubitemid 30033515)
8. Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med 2003;57:733-44. (Pubitemid 36765367)
9. Sweidan M, Zhang Y, Harvey K, Yang YH, Shen X, Yao K. Proceedings of the 2nd national workshop on rational use of antibiotics in China, Beijing, 28-30 November 2005:1-18. www.docstoc.com/docs/44755790/Proceedings-of-the-2nd- National-Workshop-on-Rational-Use.
10. Dong H, Bogg L, Rehnberg C, Diwan V. Association between health insurance and antibiotics prescribing in four counties in rural China. Health Policy 1999;48:29-45. (Pubitemid 29295396)
11. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 2011;11:692-701.
12. Apisarnthanarak A, Tunpornchai J, Tanawitt K, Mundy LM. Nonjudicious dispensing of antibiotics by drug stores in Pratumthani, Thailand. Infect Control Hosp Epidemiol 2008;29:572-5. (Pubitemid 351918041)
13. Berkley JA, Mwangi I, Ngetsa CJ, Mwarumba S, Lowe BS, Marsh K, et al. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet 2001;357:1753-7. (Pubitemid 32524205)
14. Lim VK, Cheong YM. Bacteriology turnaround time in seven Malaysian general hospitals. Malays J Pathol 1992;14:41-3.
15. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995;274:639-44.
16. Vincent J, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
17. Laxminarayan R, Ganguly NK. India's vaccine deficit: why more than half of Indian children are not fully immunized, and what can - and should - be done. Health Aff 2011;30:1096-103.
18. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455-63.
19. Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 2008;8:785-95.
20. Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 2000;31:170-6.
21. Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS 1998;12:177-84.
22. Steinfeld H, Chilonda P. Old players, new players. Livestock report 2006. Food and Agriculture Organization of the United Nations, 2006: 3-14.
23. Irungu P, Kariuki S. Analysis of economic incentives influencing farmers' use of antibiotics in livestock production in Kenya. Final report. Center for Disease Dynamics, Economics & Policy, 2011.
24. Joakim Larsson DG, Fick J. Transparency throughout the production chain - a way to reduce pollution from the manufacturing of pharmaceuticals? Regulatory Toxicol Pharmacol 2009;53:161-3.
25. Nickerson EK, Hongsuwan M, Limmathurotsakul D, Wuthiekanun V, Shah KR, Srisomang P, et al. Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One 2009;4:e4308.
26. Trape JF, Pison G, Preziosi MP, Enel C, Desgrées du LoÛ A, Delaunay V, et al. Impact of chloroquine resistance on malaria mortality. C R Acad Sci III 1998;321:689-97. (Pubitemid 28438430)
27. Health Action International. Being sick and needing medicines is a costly misfortune in many countries. 2010. www.haiweb.org/medicineprices/05012010/ Global-briefing-note.pdf.
28. Heymann DL. Resistance to anti-infective drugs and the threat to public health. Cell 2006;124:671-5. (Pubitemid 43261440)